Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey
Authors:
- James BolesJBJames Boles
- Michael WestMWMichael West
- Vicki MontgomeryVMVicki Montgomery
- Ralph TammarielloRTRalph Tammariello
- M. Louise M. PittMPM. Louise M. Pitt
- Paul GibbsPGPaul Gibbs
- Leonard SmithLSLeonard Smith
- Ross D. LeClaireRLRoss D. LeClaire
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Evaluation of a botulinum fragment C-based ELISA for measuring the humoral immune response in primatesBiologicals, 2003
- Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological WeaponsEmerging Infectious Diseases, 2002
- Development of vaccines for prevention of botulismBiochimie, 2000
- Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxinVaccine, 2000
- Fermentation, Purification, and Efficacy of a Recombinant Vaccine Candidate against Botulinum Neurotoxin Type F from Pichia pastorisProtein Expression and Purification, 2000
- Genetically Engineered Vaccines: An OverviewPlasmid, 1998
- Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinumVaccine, 1996
- Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis.Journal of Cell Biology, 1986
- Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.Journal of Cell Biology, 1986
- The Most Poisonous PoisonScience, 1959